Javascript is disabled in your browser

Startbase requires Javascript in order to display content.
Please check your browser settings and enable Javascript-Support for this website.

Biontech

News Half a percent more economic growth through biontech The fact that a single company or even a start-up leaves such a clear positive footprint on Germany's growth balance sheet is probably a novelty.

Sophie Deistler 02.07.8299

News Curevac no longer pursuing Covid vaccine The biotech wants to continue researching the underlying method, but is withdrawing its vaccine candidate.

Nils Wischmeyer 01.01.1970

News 65 million euros for cancer therapy start-up Around half a million people are diagnosed with cancer in Germany every year, and start-ups such as Biontech and Iomx are also researching therapies. The latter has now received funding for the further development of...

Lisa Marie Münster 02.07.7759

News Biontech investor backs One Logic Helmut Jeggle is apparently investing a double-digit million amount in the start-up and will receive 20 percent of the shares in return.

Lisa Marie Münster 01.01.1970

News Founder leaves Curavec for health reasons Alongside Biontech, Curevac was actually the great German hope in the fight against the coronavirus pandemic. However, its drug disappointed in an efficacy test. Now founder Ingmar Hoerr and another member of the...

Lisa Marie Münster 02.07.8200

News Biontech sales exceed two billion euros in the first quarter 2.05 billion euros in sales were made by the Mainz-based company Biontech in the first quarter of 2021, compared to 27.7 million euros in the same period last year.

Lisa Marie Münster 01.01.1970

News On average, one in five start-ups has a founder with a migration background Founders with a migration background are highly qualified and successful. However, there are often obstacles when it comes to networking and financing.

Tom Schmidtgen 01.01.1970

News Biontech and Pfizer to produce 2.5 billion vaccine doses by the end of the year The Mainz-based start-up has presented its business figures for 2020: Turnover amounted to 482 million euros, while research and development costs rose to 645 million euros.

Lisa Marie Münster 01.01.1970

News Biontech distributes record amount to venture capitalists Investors in MIG Funds 7, 8 and 9 can look forward to a total payout of EUR 600 million.

Tom Schmidtgen 01.01.1970

Reports Big deals and new start-up stars 2020 was a special year for many start-ups - and not just because of coronavirus. A brief review of the year.

Jan Schulte 01.01.1970

1